Search
元素の検索
構造の検索
Thermo Scientific Chemicals
4-Fluoro-2-methylphenylmagnesium bromide, 0.50 M in 2-MeTHF
CAS: 30897-90-6 | C7H6BrFMg | 213.33 g/mol
| 製品番号（カタログ番号） | 数量 |
|---|---|
| H54865.AE または、製品番号H54865-AE | 100 mL |
仕様
CAS30897-90-6
化学物質名または材質4-Fluoro-2-methylphenylmagnesium bromide
Concentration or Composition (by Analyte or Components)0.50M in 2-MeTHF
DOT情報Transport Hazard Class: 3; Packing Group: II; Proper Shipping Name: FLAMMABLE LIQUIDS, CORROSIVE, N.O.S.
式量213.33
さらに表示
It is an important raw material and intermediate used in organic synthesis, Pharmaceuticals, agrochemicals and dyestuffs.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
It is an important raw material and intermediate used in organic synthesis, Pharmaceuticals, agrochemicals and dyestuffs.
Solubility
Soluble in 0.5 M in Tetrahydrofuran.
Notes
Store at 4°C. Air
It is an important raw material and intermediate used in organic synthesis, Pharmaceuticals, agrochemicals and dyestuffs.
Solubility
Soluble in 0.5 M in Tetrahydrofuran.
Notes
Store at 4°C. Air
RUO – Research Use Only
General References:
- Shigeo Hayashi.; Katsuyo Ohashi.; Eriko Nakata.; Chie Emoto. Discovery of 1-(β-amino substituted-β-alanyl)-N,N-dimethylindoline-2-carboxamides as novel nonpeptide antagonists of nociceptin/orphanin FQ receptor: Efficient design, synthesis, and structure-activity relationship studies.Eur. J. Med. Chem. 2012, 55 228-242.
- Junya Shirai.; Hideyuki Sugiyama.; Shinji Morimoto.; Hironobu Maezaki.; Yasuharu Yamamoto.; Satoshi Okanishi.; Izumi Kamo.; Shiho Matsumoto.; Keiko Ishigami;. Nobuhiro Inatomi.; Akio Imanishi.; Makiko Kawamoto.; Naoki Tarui.; Tadatoshi Hashimoto.; Yoshinori Ikeura. Novel 3-phenylpiperidine-4-carboxamides as highly potent and orally long-acting neurokinin-1 receptor antagonists with reduced CYP3A induction. Bioorg. Med. Chem. 2012, 20 (2),962-977.